Compare NICE Ltd (NICE) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs Novartis AG — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 49.1× NICE Ltd's market cap, and Novartis AG pays a 3.17% dividend while NICE Ltd pays none. Which is the better fit depends on your goals.
| NICE | NVS | |
|---|---|---|
Market Cap | $5.91B | $290.25B |
Sector | Technology | Health |
52-Week High | $170.37 | $168.62 |
52-Week Low | $83.15 | $113.50 |
Enterprise Value | $5.69B | $330.27B |
Dividend Yield | — | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
